Skip to main content
. Author manuscript; available in PMC: 2024 Oct 18.
Published in final edited form as: J Pain Symptom Manage. 2021 Sep 23;63(2):210–220. doi: 10.1016/j.jpainsymman.2021.09.009

Table 1.

Demographic and Clinical Characteristics of Patients in the Intention to Treat Population

Characteristics High-dose EA (n = 19) Low-dose EA (n = 20) Control Group (n = 19)
Age (year), mean ± SD 55.00±12.41 58.75±8.85 53.95±12.19
Gender
 Male 15 (78.95%) 11 (55.00%) 10 (52.63%)
 Female 4 (21.05%) 9 (45.00%) 9 (47.37%)
ECOG physical status score
 0 2 (10.53%) 2 (10.00%) 3 (15.79%)
 (1–2)* 17 (89.47%) 18 (90.00%) 16 (84.21%)
Stage
 II 5 (26.32%) 6 (30.00%) 7 (36.84%)
 III 14 (73.68%) 14 (70.00%) 12 (63.16%)
Resection extent
 Total/proximal gastrectomy 9 (47.37%) 9 (45.00%) 8 (42.11%)
 Distal gastrectomy 10 (52.63%) 11 (55.00%) 11 (57.89%)
Surgical approach
 Laparoscope 9 (47.37%) 10 (50.00%) 9 (47.37%)
 Open surgery 10 (52.63%) 10 (50.00%) 10 (52.63%)
Neo-adjuvant chemotherapy
 Yes 4 (21.05%) 2 (10.00%) 2 (10.53%)
 No 15 (78.95%) 18 (90.00%) 17 (89.47)
Days from surgery to adjuvant
chemotherapy, median (range) 29 (20–58) 30 (22–65) 34 (19–52)
Number of acupoints, median (range) 12 (10–14) 12 (10–13) -

Abbreviations: EA = electro-acupuncture; SD = standard deviation; ECOG = Eastern Cooperative Oncology Group.

*

Only 1 patient in low-dose group was with ECOG PS=2.